1. Zhao, Ru, Feng, Tingting, Gao, Lin, Wang, Lin, Han, Bo. 2022. PPFIA4 promotes castration-resistant prostate cancer by enhancing mitochondrial metabolism through MTHFD2. In Journal of experimental & clinical cancer research : CR, 41, 125. doi:10.1186/s13046-022-02331-3. https://pubmed.ncbi.nlm.nih.gov/35382861/
2. Huang, Jia, Yang, Meiling, Liu, Zhaoxia, Cao, Ting, Yang, Xuefeng. 2021. PPFIA4 Promotes Colon Cancer Cell Proliferation and Migration by Enhancing Tumor Glycolysis. In Frontiers in oncology, 11, 653200. doi:10.3389/fonc.2021.653200. https://pubmed.ncbi.nlm.nih.gov/34094943/
3. Katoh, Masuko, Katoh, Masaru. . Identification and characterization of human PPFIA4 gene in silico. In International journal of molecular medicine, 12, 1009-14. doi:. https://pubmed.ncbi.nlm.nih.gov/14612982/
4. Tan, Shu, Yu, Hao, Xu, Ye, Zhao, Yue, Lou, Ge. 2023. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming. In Medical oncology (Northwood, London, England), 40, 272. doi:10.1007/s12032-023-02144-0. https://pubmed.ncbi.nlm.nih.gov/37596446/
5. Fu, Fangmei, Niu, Rui, Zheng, Minying, Fu, Wenzheng, Zhang, Shiwu. 2023. Clinicopathological Significances and Prognostic Value of PPFIA4 in Colorectal Cancer. In Journal of Cancer, 14, 24-34. doi:10.7150/jca.78634. https://pubmed.ncbi.nlm.nih.gov/36605492/
6. Sun, Qi, Wang, Huxia, Xiao, Baoan, Xue, Dong, Wang, Guanghui. 2022. Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma. In Frontiers in oncology, 12, 954366. doi:10.3389/fonc.2022.954366. https://pubmed.ncbi.nlm.nih.gov/35924146/
7. Sourbron, Jo, Jansen, Katrien, Aerts, Nele, Lagae, Lieven. 2021. PPFIA4 mutation: A second hit in POLG related disease? In Epilepsy & behavior reports, 16, 100455. doi:10.1016/j.ebr.2021.100455. https://pubmed.ncbi.nlm.nih.gov/34095804/
8. Xu, Zijun, Xu, Lijuan, Liu, Liping, Li, Yanbing, Guan, Hongyu. 2021. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma. In Frontiers in oncology, 11, 625452. doi:10.3389/fonc.2021.625452. https://pubmed.ncbi.nlm.nih.gov/33954109/